Skip to NavigationSkip to content

News

Researchers from RMIT University in Australia were tasked with developing a more effective breath test for determining what was happening in the...
Sri Lanka is set to build its first-ever exclusive pharmaceutical manufacturing zone as part of an investment exceeding $10 million.
A collaboration that sees six pharma players come together to fund the sequencing of a particular section of DNA of 500,000 participants has been...
Shire has revealed that it now plans to move forward by separating its operations into two distinct divisions: rare disease and neuroscience.
After an hour-long meeting with the Prime Minister, during the cabinet reshuffle, Jeremy Hunt emerged with the new title of Secretary of State for...
The signs were already there for Axovant Sciences’ key drug, intepirdine, when it posted poor results from a recent study back in September...
The Sanofi-Alynylam alliance has been in place since 2014, with the latest development seeing the two companies each take their own commercialisation...
The FDA has approved the indication expansion of Amgen's Xgeva to include the treatment of multiple myeloma.
Celgene is prepared to gamble $7 billion on a treatment that had previously been shut down by the FDA over safety concerns due to the potential the...
Ablynx has rejected an offer of €2.6 billion by Novo Nordisk to acquire the Belgian biotech.
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches